A Multicenter Cohort Study of Immune Dysregulation Disorders Caused by ELF4 Variants in China

J Clin Immunol. 2023 Jul;43(5):933-939. doi: 10.1007/s10875-023-01453-3. Epub 2023 Feb 23.

Abstract

Patients with DEX (deficiency in ELF4, X-linked) were recently reported by our team and others, and cases are very limited worldwide. Our knowledge of this new disease is currently preliminary. In this study, we described 5 more cases presenting mainly with oral ulcer, inflammatory bowel disease-like symptoms, fever of unknown origin, anemia, or systemic lupus erythematosus. Whole exome sequencing identified potential pathogenic ELF4 variants in all cases. The pathogenicity of these variants was confirmed by the detection of ELF4 expression in peripheral blood mononuclear cells from patients and utilizing a simple IFN-b luciferase reporter assay, as previously reported. Our findings significantly contribute to the current understanding of DEX.

Keywords: DEX; ELF4; immune dysregulation disorders; inborn errors of immunity; novel variants.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Cohort Studies
  • DNA-Binding Proteins
  • Humans
  • Immune System Diseases*
  • Leukocytes, Mononuclear
  • Lupus Erythematosus, Systemic*
  • Transcription Factors

Substances

  • ELF4 protein, human
  • DNA-Binding Proteins
  • Transcription Factors